Ischemic Stroke 101. David Y. Huang, MD, PhD
|
|
- Madeline Page
- 7 years ago
- Views:
Transcription
1 Ischemic Stroke 101 David Y. Huang, MD, PhD Director, UNC Hospitals Stroke Center Associate Professor, Department of Neurology UNC School of Medicine
2 Outline What is a stroke? Acute Stroke: EMS Management t-pa» Use of intravenous (IV) t-pa from 0-3 hours» IV rt-pa hours» Treatment delays negatively impact overall benefit Interventional Treatments at UNC» Intra-arterial (IA) rt-pa» MERCI Clot Retriever» Penumbra System 8/28/2012 2
3 What is a STROKE? Definition: A stroke is an illness of sudden onset causing injury to the brain that results from occlusion or rupture of a blood vessel that supplies a specific region of the brain STROKE IS AN EMERGENCY
4 Circulation of the Brain 4
5 5
6 Functional Map of the Brain 6
7 STROKE CLASSIFICATIONS Ischemic Strokes» blood vessel occlusion Hemorrhagic Strokes» blood vessel rupture
8 STROKE SUBTYPES Albers GW et al. Chest. 1998;114:683S-698S. Rosamond WD et al. Stroke. 1999;30:
9 STROKE is a BRAIN ATTACK Time = Brain Early Recognition = Brain Saved STROKE IS AN EMERGENCY
10 Stroke Care: AHA 7 D s Adams et al. Stroke (2007) 38:
11 Acute Stroke: Barriers to Treatment A large proportion of stroke patients do not know the signs or symptoms of stroke Only 5-20% of stroke patients seek medical attention within 3 hours of symptom onset
12 What are some barriers to calling 911? When raised in rural townships you don t go to the doctor immediately. You lie down and rest first. Older African American men were highly suspicious of the medical community and perceived they received less treatment than whites. Men admitted to being less likely to go to a doctor or hospital for care thinking they would just get better. Denial about the possibility of having a major illness. High cost or lack of insurance prohibited seeking care. Did not want the embarrassment of overreacting to symptoms.
13 Stroke: EMS Management Time Is Brain and Lost Time Is Lost Brain
14 EMS Evaluation ABCs/CABs History» Onset of symptoms» Recent events Stroke, Myocardial infarction, Trauma, Surgery, Bleeding» Comorbid diseases Hypertension Diabetes mellitus Vascular disease» Stroke» CAD» PVD» Medications Anticoagulants Insulin Antihypertensives» Allergies Stroke Screening Tools» Cincinnati Prehospital Stroke Scale (CPSS)» Los Angeles Prehospital Stroke Screen (LAPSS)» Sensitivity for identifying patients with stroke Standard training 61% to 66% Training with stroke assessment tool 86% to 97% Adams et al. Stroke (2007) 38:
15 Screening for Stroke Cincinnati Prehospital Stroke Scale Normal: Abnormal: Normal: Abnormal: Normal: Abnormal: Facial Droop Both sides of the face move equally One side of the face does not move at all Arm Drift Both arms move equally or not at all One arm drifts compared with the other Speech Patient uses correct words with no slurring Slurred or inappropriate words or mute Source: University of Cincinnati College of Medicine.
16 Screening for Stroke Los Angeles Prehospital Stroke Screen (LAPSS) 1. Age >45 years 2. History of seizures or epilepsy absent 3. Symptom duration <24 hours 4. At baseline, patient is not wheelchair bound or bedridden 5. Blood glucose between 60 and 400 mg/dl 6. Obvious asymmetry (right vs left) in any of the following 3 exam categories (must be unilateral):» Facial smile/grimace» Grip» Arm strength AHA Adult Stroke Guidelines. Circulation. 2005;112(suppl 24):IV-1-IV-203.
17 EMS Management Adams et al. Stroke (2007) 38:
18 Objectives for EMS Stabilization of the patient Rapid identification of stroke as the cause of the patient s findings Elimination of co-morbid conditions that could mimic stroke Rapid transportation of the patient to the closest appropriate ED Notification of the receiving institution about impending arrival of a patient with suspected stroke Adams et al. Stroke (2007) 38:
19 EMS Management While EMS has the ability to predict stroke, only imaging (CT or MRI) can determine whether a person is suffering from an ischemic stroke or a hemorrhagic stroke. Early Ischemic Intracerebral Hemorrhage Epidural Hemorrhage Late Ischemic Subarachnoid Hemorrhage Subdural Hemorrhage 19
20 N.C. Stroke Care Collaborative Registry 13,894 records evaluated Arrival by EMS (versus private transport) was associated with faster evaluations Brain imaging completed within 25 minutes» EMS with prenotification: risk ratio, 3.0; 95% CI, 2.1 to 4.1» EMS without prenotification: risk ratio, 1.9; 95% CI, 1.6 to 2.3) and Brain imaging interpreted within 45 minutes» EMS with prenotification: ratio, 2.7; 95% CI, 2.3 to 3.3» EMS without prenotification: ratio, 1.7; 95% CI, 1.4 to 2.1 Stroke. 2011;42: Published online June 9, 2011
21 UNC Hospitals ED Stroke Pre-Hospital Notification» Radio» Secondary process ED Charge Nurse ED Attending (main ED number) 8/28/
22 Acute Ischemic Stroke Treatments Rapid triage model after trauma and MI For IV tpa eligible patients: Golden Hour» 60 minute door-to-needle time Protocols and training to insure MDs and nurses are comfortable assessing and administering treatment 22
23 NINDS t-pa Trial Endpoint rt-pa Placebo Odds Ratio (95% CI) P Favorable Outcome (mrs 0-1) at 90 Days (%) ( ) As compared with patients given placebo, patients treated with t-pa were at least 30 percent more likely to have minimal or no disability at three months on the assessment scales. Endpoints rt-pa Placebo P Symptomatic ICH, NINDS definition (%) < Mortality at 3 months (%) NINDS Part 2, NEJM1995:
24 t-pa: the sooner, the better The odds ratio for favorable outcome at 3 months in patients treated with t-pa decreases as a function of the interval between stroke onset and onset of the treatment (OTT) Source: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-pa stroke trials. Lancet. 2004; 363(9411):
25 ECASS-3 A randomized, placebo-controlled, phase 3 trial conducted at 130 sites in 19 European countries to examine safety and efficacy of rt-pa in the 3 to 4.5 hour treatment window; 821 patients aged 18 to 80 years were enrolled 10% of patients were treated between 3 and 3.5 hours, 46.8% between 3.5 and 4 hours, and 39.2% between 4 and 4.5 hours Mean time to treatment was 3 hours and 59 minutes Endpoint rt-pa Placebo Odds Ratio (95% CI) P Favorable Outcome (mrs 0-1) at 90 Days (%) ( ).04 Endpoints rt-pa Placebo P Symptomatic ICH, NINDS definition (%) Mortality (%) NEJM :
26 ECASS-3 Differences compared to NINDS» Patients older than 80 years were not studied» Patients with a combination of previous stroke and diabetes mellitus were excluded» Patients taking oral anticoagulant treatment were excluded» Patients with severe stroke as assessed clinically (e.g., NIHSS score >25) or by appropriate imaging techniques were excluded As a result of this study, many centers started offering rt- PA in the hour window» Considered off-label usage 26
27 Intra-Arterial Treatments 3-6 hours» Intra-arterial tpa: within 6 hours of symptom onset 3-8 hours» MERCI Clot Retrieval» Penumbra System
28 MERCI: Basilar Case Study 31 year old male NIHSS Score 10 (dysarthria and right-sided weakness) Progressed to unresponsive with vertical nystagmus Symptom Onset to Treatment 4h 30min Source: Yu et al. Neurology (2003) 61:
29 MERCI: Basilar Case Study NIHSSS 24 hours 0 30 days 0 mrs 90 days 0 Source: Yu et al. Neurology (2003) 61:
30 PENUMBRA System Clot Retrieved Pre-PENUMBRA Post-PENUMBRA
31 Intra-Arterial Therapies Intra-Arterial Therapies are not tpa substitutes!» Pros Expand the treatment window» Cons Not widely available currently limited to comprehensive stroke centers with interventional capabilities Narrow eligibility criteria Anatomical limitations IA therapies are not as well-studied Benefits are controversial» IA rt-pa is off-label» Although the FDA-approved devices have demonstrated that they can remove a clot, no study has shown that the intervention benefits a patient s long-term outcome 31
32 Related Trial Comparisons* Revascularization Stroke 2005;36: AJNR 2006;27: JAMA1999;282: N. Eng J M 2004;351:2170 * Population observation rates, and 95% Exact Binomial Confidence Intervals
33 Related Trial Comparisons* mrs 2 at 90 Days PROACT II Control (n=59) 4 1. Stroke 2005;36: AJNR 2006;27: JAMA1999;282: N. Eng J M 2004;351:2170 * Population observation rates, and 95% Exact Binomial Confidence Intervals
34 Related Trial Comparisons* Symptomatic ICH PROACT II Control (n=59) 4 1. Stroke 2005;36: AJNR 2006;27: JAMA1999;282: N. Eng J M 2004;351:2170 * Population observation rates, and 95% Exact Binomial Confidence Intervals
35 The standard for acute stroke care is still IV rt-pa Intra-arterial treatments are not equivalent to the IV rt-pa Systems for acute stroke care should be designed to optimize delivery of standard stroke care (IV rt-pa) Other stroke interventions should be considered rescue for patients who are not eligible for IV tpa 35
36 UNC Comprehensive Stroke Center Ground & Air transportation Emergency Services: ED & VIR Neurosciences ICU ISCU: Step-Down 6NSH Neurology Acute Care Rehab Unit Stroke Clinic UNC Transfer Center UNC Neurology (Stroke) clinic offices NP
37 UNC Stroke NP Program Susan Wilson, FNP » Provides post-discharge support for patients and caregivers» Provides follow-up to referring MDs and PCPs» Provides follow-up to EMS providers who bring patients directly to UNC EMS information portal 37
38 Summary Time is Brain!» Assess and transport patients quickly rt-pa» IV rt-pa is the indicated treatment for eligible patients presenting in the 3-hour window» Treatment delays have significant impact on overall benefit» IV rt-pa from hours is a reasonable treatment and is recommended for most acute stroke patients Interventional Treatments» Limited availability» Only a small fraction of stroke patients qualify clinically» Benefits not proven in large-scale studies On the Horizon» Work continues to find new (more effective and safer) ways to treat stroke
Developing a Dynamic Team Approach to Stroke Care. Emergency Medical Services 2015
Developing a Dynamic Team Approach to Stroke Care Emergency Medical Services 2015 Why Stroke, Why now? A recent study showed that 80 percent of people in the United States live within an hour s drive of
More informationTIME LOST IS BRAIN LOST. TARGET: STROKE CAMPAIGN MANUAL
TIME LOST IS BRAIN LOST. TARGET: STROKE CAMPAIGN MANUAL 2010, American Heart Association TARGET: STROKE CAMPAIGN MANUAL 01 INTRODUCTION Welcome to the Target: Stroke. The purpose of this manual is to provide
More informationEMS Management of Stroke. Deaver Shattuck, M.D. Brian Wiseman, M.D. Keith Woodward, M.D.
EMS Management of Stroke Deaver Shattuck, M.D. Brian Wiseman, M.D. Keith Woodward, M.D. Financial Disclosure: No relevant financial relationship exists Working Together to End Stroke Formed in 2013 Identified
More informationTherapeutic Management Options for. Acute Ischemic Stroke Anna Rosenbaum, MD
Therapeutic Management Options for Acute Ischemic Stroke Anna Rosenbaum, MD Epidemiology Epidemiology 4 th leading cause of death in the United States 1 Leading cause of disability Increase in projected
More informationSTROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE
STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE CASE REPORT: ACUTE STROKE MANAGEMENT 90 YEAR OLD WOMAN, PREVIOUSLY ACTIVE AND INDEPENDENT, CHRONIC ATRIAL FIBRILLATION,
More informationSTROKE TRAINING FOR EMS PROFESSIONALS
1 STROKE TRAINING FOR EMS PROFESSIONALS COURSE OBJECTIVES About Stroke Stroke Policy Recommendations Stroke Protocols and Stroke Hospital Care Stroke Assessment Tools Pre-Notification Stroke Treatment
More informationTPA, STROKE, & TELEMEDICINE. Improving utilization and improving outcomes in a constantly evolving field
TPA, STROKE, & TELEMEDICINE Improving utilization and improving outcomes in a constantly evolving field OVERVIEW tpa inclusion and exclusion evolution Challenges to tpa administration Target:Stroke Telemedicine
More informationLevel III Stroke Center Data Collection Requirements
Who? Level III Stroke Center Data Collection Requirements All LERN Level III Stroke Centers. LERN Level I and II Stroke Centers have reporting requirements to The Joint Commission or other Board approved
More informationGlobal Objectives. Use of the NIH Stroke Scale (NIHSS) in Emergency Department Patients with Acute Stroke. Why Do This Exercise? Session Objectives
1 Use of the NIH Scale (NIHSS) in Emergency Department Patients with Acute Professor Department of Emergency Medicine University of Illinois College of Medicine Chicago, IL Global Objectives Improve pt
More informationGP workshop. Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre
GP workshop Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre Stroke: the Facts Stroke: the Facts Every 5 minutes someone in the UK has a stroke 1 in 4 men and 1 in 5 women will have a stroke
More informationKing County EMS Stroke Quality Improvement Program
King County EMS Stroke Quality Improvement Program A Report from the King County EMS Medical QI Section March 2012 Prepared by Sofia Husain, Jim Duren, and Norm Nedell OBJECTIVE The goal of the King County
More informationSTROKE OCCURRENCE SYMPTOMS OF STROKE
STROKE OCCURRENCE SYMPTOMS OF STROKE The symptoms of stroke depend on what part of the brain is affected and how large an area is involved. A stroke is a sudden event accompanied by one or more of the
More informationApproved: Acute Stroke Ready Hospital Advanced Certification Program
Approved: Acute Stroke Ready Hospital Advanced Certification Program The Joint Commission recently developed a new Disease- Specific Care Advanced Certification program for Acute Stroke Ready Hospitals
More informationBuilding an Emergency Response to Acute Stroke
Great Lakes Stroke Network August 2006 Building an Emergency Response to Acute Stroke Wende N. Fedder RN, BSN, MBA Director, Stroke & Neurovascular Services Alexian Brothers Hospital Network Elk Grove
More informationMaking the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA
Making the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA Disclosures Jeanie Luciano Genentech speakers bureau Claranne Mathiesen - none 1 Objective
More informationIS EMS A PART OF YOUR STROKE TEAM?
IS EMS A PART OF YOUR STROKE TEAM? S. R. Scott, MD Chief of Service Associate EMS Medical Director Department of Emergency Medicine New Jersey Medical School-Newark Presenter Disclosure Information Sandra
More informationNew Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013
New Treatments for Stroke Prevention in Atrial Fibrillation John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 Classification Paroxysmal atrial fibrillation (AF) Last < 7
More informationDisclosures. Georgia Facts. Stroke System Models. Telestroke. The World is Flat : A Brief Future of Acute Stroke Care
Telestroke The World is Flat : A Brief Future of Acute Stroke Care David C. Hess M.D. Department of Neurology Medical College of Georgia Disclosures Genentech Speaker s Bureau Boehringer Ingelheim Speaker
More informationACT FAST! Stroke is prevalent and life-threatening
STROKE is an Emergency. ACT FAST! Stroke is prevalent and life-threatening 780,000 strokes are estimated to occur annually in the United States 1 Stroke is the 3rd leading cause of death and a leading
More information4th Annual New York Stroke Conference Maximizing Stroke Quality of Care: Key Ingredients
4th Annual New York Stroke Conference Maximizing Stroke Quality of Care: Key Ingredients Thomas Kwiatkowski, MD Medical Director : Center for Emergency Medical Services NSLIJ No relevant financial relationships
More informationStroke Systems of Care
Stroke Systems of Care Ashutosh P. Jadhav, MD PhD Assistant Professor, Neurology and Neurological Surgery Center for Neuro-endovascular Therapy UPMC Stroke Institute Pittsburgh, PA Stroke chain of survival
More information2016 International Stroke Conference Hot Topics Lori M. Massaro, MSN, CRNP Kari Moore, MSN, AGACNP-BC
2016 International Stroke Conference Hot Topics Lori M. Massaro, MSN, CRNP Kari Moore, MSN, AGACNP-BC Disclosures Lori M. Massaro, MSN,CRNP speakers bureau Genentech Kari Moore, MSN, AGACNP-BC -none 1
More informationJHS Stroke Program. 2016 JHS Annual Mandatory Education
JHS Stroke Program 2016 JHS Annual Mandatory Education Learner Objectives At the conclusion of this module learners will be able to: State the definition of stroke Discuss the pathophysiology of stroke
More informationThe Clinical Evaluation of the Comatose Patient in the Emergency Department
The Clinical Evaluation of the Comatose Patient in the Emergency Department patients with altered mental status (AMS) and coma. treat patients who present to the Emergency Department with altered mental
More informationDepartment of Veterans Affairs VHA DIRECTIVE 2011-038 Veterans Health Administration Washington, DC 20420 November 2, 2011
Department of Veterans Affairs VHA DIRECTIVE 2011-038 Veterans Health Administration Washington, DC 20420 TREATMENT OF ACUTE ISCHEMIC STROKE (AIS) 1. PURPOSE: This Veterans Health Administration (VHA)
More informationALBERTA PROVINCIAL STROKE STRATEGY (APSS)
ALBERTA PROVINCIAL STROKE STRATEGY (APSS) Stroke Systems of Care Key Components APSS Pillar Recommendations March 28, 2007 1 The following is a summary of the key components and APSS Pillar recommendations
More informationAHA/ASA Guideline. The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
AHA/ASA Guideline Guidelines for the Early Management of Adults With Ischemic Stroke A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council,
More informationMain Effect of Screening for Coronary Artery Disease Using CT
Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,
More informationDIAGNOSTIC CRITERIA OF STROKE
DIAGNOSTIC CRITERIA OF STROKE Diagnostic criteria are used to validate clinical diagnoses. Here below MONICA diagnostic criteria are reported. MONICA - MONItoring trends and determinants of CArdiovascular
More informationREGIONAL STROKE TRIAGE PLAN
1 REGIONAL STROKE TRIAGE PLAN Rappahannock EMS Council 435 Hunter Street Fredericksburg, VA 22401 Phone: (540) 373-0249 Fax: (540) 373-0249 E-mail: rems@vaems.org www.rems.vaems.org Approved by Board of
More informationPreparing Your Hospital for Primary Stroke Certification Authors: Wendy J. Smith, BS, MA, RES, RCEP, RN Claranne Mathiesen, MSN, RN, CNRN
Preparing Your Hospital for Primary Stroke Certification Authors: Wendy J. Smith, BS, MA, RES, RCEP, RN Claranne Mathiesen, MSN, RN, CNRN Disclosures Wendy J. Smith-I have no actual or potential conflict
More informationPE finding: Left side extremities mild weakness No traumatic wound No bloody otorrhea, nor rhinorrhea
Case report A 82-year-old man was suffered from sudden onset spasm of extremities then he fell down to the ground with loss of consciousness. He recovered his consciousness 7-8 mins later but his conscious
More informationTHE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT
THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological
More informationSTATEMENT OF STANDARD
OHSU HEALTH CARE SYSTEM PRACTICE STANDARD Acute Stroke Practice Standard for the Emergency Department (includes ischemic stroke, TIAs, intracerebral hemorrhage, and non-subarachnoid hemorrhage), PS 01.11
More informationIschaemic stroke 85% (85 in every 100 strokes)
UNDERSTANDING STROKE DUE TO INTRACEREBRAL HAEMORRHAGE This factsheet provides information for people who have had a stroke due to an intracerebral (bleed in the brain) and for their families and carers.
More informationAnticoagulation For Atrial Fibrillation
Anticoagulation For Atrial Fibrillation New Agents In A New Era Arjun V Gururaj, MD Arrhythmia and Electrophysiology Nevada Heart and Vascular Center Disclosures Biotronik Speaker Clinical investigator
More information4/24/2015. Urgent, STAT, Super STAT, ASAP! Achieving timely lab testing for the Emergency Department. Learning Objectives.
Urgent, STAT, Super STAT, ASAP! Achieving timely lab testing for the Emergency Department Nichole Korpi-Steiner, PhD, DABCC, FACB University of North Carolina Chapel Hill, NC Learning Objectives Describe
More informationWhat s New in Stroke?
5 th McMaster University Review Course in INTERNAL MEDICINE What s New in Stroke? Robert Hart, M.D. HHS / McMaster Stroke Program Department of Medicine (Neurology) McMaster University Hamilton, Ontario
More informationEfficacy, safety and preference study of a insulin pen PDS290 vs. a Novo Nordisk marketed insulin pen in diabetics
Efficacy, safety and preference study of a insulin pen PDS290 vs. a Novo Nordisk marketed insulin pen in diabetics This trial is conducted in the United States of America (USA). The aim of this clinical
More informationEmerging therapies for Intracerebral Hemorrhage
Emerging therapies for Intracerebral Hemorrhage Chitra Venkat, MBBS, MD, MSc. Associate Professor of Neurology and Neurological Sciences Stroke and Neurocritical Care. Stanford University Learning objectives
More informationREGIONAL SUSPECTED STROKE PROTOCOL
1. Stroke refers to any spontaneous damage to the brain caused by an abnormality of the blood supply by means of a clot or bleed. Strokes should be treated emergently. During a stroke, up to 2 million
More informationJournal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators
Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators Shaikha Al Naimi Doctor of Pharmacy Student College of Pharmacy Qatar University
More informationSecondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence
Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for
More informationAmerican Stroke Association Highlights Carla D. English, MHS, MHSA
AMERICAN STROKE ASSOCIATION HIGHLIGHTS 1 CARLA D. ENGLISH, MHS, MHSA QUALITY & SYSTEMS IMPROVEMENT GREATER SOUTHEAST AFFILIATE ASA VISION: Empower people to live longer, healthier lives free of stroke
More informationEvaluating ED Patients with Transient Ischemic Attack: Inpatient vs. Outpatient Strategies
Evaluating ED Patients with Transient Ischemic Attack: Inpatient vs. Outpatient Strategies Michael A. Ross MD FACEP Associate Professor of Emergency Medicine Wayne State University School of Medicine Detroit
More informationHow To Help A Stroke Patient
Rishi Gupta, MD Susan Zimmermann, RN, BSN, CNRN Kerrin Connelly, RN, MSN, MPH Cheri Kommor, RN, CEN, CFRN, NREMT-P Rishi Gupta FINANCIAL DISCLOSURE: Consultant: Stryker Neurovascular, Covidien DSMB: Rapid
More informationUPDATED INCLUSION AND EXCLUSION CRITERIA FOR IV TPA ADMINISTRATION ACUTE STROKE TREATMENT: AN UPDATE GOALS OF TALK
ACUTE STROKE TREATMENT: AN UPDATE James M. Gebel MD MS FAHA Medical Director Akron General Medical Center Cerebrovascular Center GOALS OF TALK Review changes to IV tpa administration as per new 2013 AHA
More informationTreatment of Ischemic Stroke in the Neuro-ICU
Treatment of Ischemic Stroke in the Neuro-ICU Gary L. Bernardini, MD, PhD Professor of Neurology Director, Stroke and Neurocritical Care Departments of Neurology and Neurosurgery Albany Medical Center
More informationADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes
ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,
More informationACUTE STROKE PATHWAY
ACUTE STROKE PATHWAY THERE IS A NEED FOR STATEWIDE STROKE SYSTEM OF CARE ALL MISSISSIPPIANS SHOULD BE ABLE TO ACCESS NEW PROTOCOLS FOR STROKE TREATMENT JOINT EFFORT WITH EMS, PHYSICIANS, HOSPITALS AND
More information6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology
Objectives Acute Coronary Syndromes Epidemiology and Health Care Impact Pathophysiology Unstable Angina NSTEMI STEMI Clinical Clues Pre-hospital Spokane County EMS Epidemiology About 600,000 people die
More informationLet s talk about: Stroke
Let s talk about: Stroke February 20 th 2013 Laura Wilson Christine Stables Questions 1. Why is knowing about stroke important? 2. What exactly is a stroke and what are the symptoms? 3. What should I do
More informationPerspectives on the Selection and Duration of Dual Antiplatelet Therapy
Perspectives on the Selection and Duration of Dual Antiplatelet Therapy Dominick J. Angiolillo, MD, PhD, FACC, FESC, FSCAI Director of Cardiovascular Research Associate Professor of Medicine University
More informationAHA/ASA Scientific Statement
AHA/ASA Scientific Statement Metrics for Measuring Quality of Care in Comprehensive Stroke Centers: Detailed Follow-Up to Brain Attack Coalition Comprehensive Stroke Center Recommendations A Statement
More informationAppendix L: HQO Year 1 Implementation Priorities
Appendix L: HQO Year 1 Implementation Priorities Chronic Obstructive Pulmonary Disease (Source: COPD Chairs) Non-Invasive Positive Pressure Ventilation Early Ambulation If possible, seek patient preferences
More informationThrombolysis for Ischemic Stroke: Past, Present, and Future. LGH Stroke Symposium Oct 26, 2013
Thrombolysis for Ischemic Stroke: Past, Present, and Future LGH Stroke Symposium Oct 26, 2013 1 2 Thrombolytic Therapy Outcomes at 3 Months from tpa Treatment of Stroke 4 Historical Landmarks 5 Other Thrombolytics
More informationGuidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes
Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center
More informationBios 6648: Design & conduct of clinical research
Bios 6648: Design & conduct of clinical research Section 1 - Specifying the study setting and objectives 1. Specifying the study setting and objectives 1.0 Background Where will we end up?: (a) The treatment
More informationBasic Stroke for the New Recruit
Basic Stroke for the New Recruit Authors Erin Conahan MSN, RN, ACNS-BC, CNRN, SCRN Julie FussnerBSN, RN, CPHQ, SCRN The authors have nothing to disclose. 1 Objectives List causes of small vessel stroke
More informationCartographic Modeling Lab University of Pennsylvania
When Minutes Matter: OPTIMIZING ACCESS TO HEALTH CARE Vicky Tam- Project Manager/GIS Analyst Karl Dailey - Database Analyst ESRI User Conference, 2015 Cartographic Modeling Lab University of Pennsylvania
More informationFOR THE PREVENTION OF ATRIAL FIBRILLATION RELATED STROKE
www.bpac.org.nz keyword: warfarinaspirin FOR THE PREVENTION OF ATRIAL FIBRILLATION RELATED STROKE Key Concepts In atrial fibrillation (AF) warfarin is more effective than aspirin for stroke prevention.
More informationMeasure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care
Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
More informationCLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014
CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014 e 55 0495 2 Emergency Department (ED)- 1 Emergency Department Throughput Median time from
More informationAR SAVES. INTRODUCTION AND UPDATES FOR ER PHYSICIANS. Nicolas Bianchi, MD. August 23 rd, 2012.
1 AR SAVES INTRODUCTION AND UPDATES FOR ER PHYSICIANS. Nicolas Bianchi, MD. August 23 rd, 2012. 2 Objectives To provide an introduction and overall description of AR SAVES as a Telestroke Network in the
More informationCASE SELECTION: EVALUATING THE RECORDS TO DETERMINE WHICH CASES TO REJECT OR TAKE
CASE SELECTION: EVALUATING THE RECORDS TO DETERMINE WHICH CASES TO REJECT OR TAKE Philip C. Henry, Esquire Henry, Spiegel, Fried & Milling, LLP Suite 2450 950 East Paces Ferry Road Atlanta, Georgia 30326
More information9/5/14. Objectives. Atrial Fibrillation (AF)
Novel Anticoagulation for Prevention of Stroke in Patients with Atrial Fibrillation Objectives 1. Review current evidence on use of warfarin in individuals with atrial fibrillation 2. Compare the three
More informationA Collaborative Effort to Improve Emergency Stroke Care: Mobile Stroke Unit
A Collaborative Effort to Improve Emergency Stroke Care: Mobile Stroke Unit What can we do to cut down the time it takes to give a clot dissolving drug (tpa)? MOBILE STROKE UNIT! Mobile Stroke Unit Mobile
More informationThe largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38
Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac
More informationFULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES
FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES Niteesh K. Choudhry, MD, PhD Harvard Medical School Division of Pharmacoepidemiology and Pharmacoeconomics
More informationDuration of Dual Antiplatelet Therapy After Coronary Stenting
Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are
More informationA Comparison of Hemorrhagic and Ischemic Strokes among Blacks and Whites:
A Comparison of Hemorrhagic and Ischemic Strokes among Blacks and Whites: A Population-Based Study That Will Demonstrate Issues Surrounding EHR Access and Research Brett Kissela, MD, MS Professor Vice-Chair
More informationDiabetes and Stroke. Understanding the connection between diabetes and the increased risk of stroke
Diabetes and Stroke Understanding the connection between diabetes and the increased risk of stroke Make the Connection Almost 26 million people in the U.S. roughly 8 percent of the population have diabetes.
More informationPrehospital Management of Stroke. Todd J. Crocco, MD
After returning home from the supermarket, a woman finds her 67-year-old husband in the kitchen with slurred speech and left-sided weakness. He was acting normally when she left the house earlier that
More informationAHA/ASA Ischemic Stroke Performance Measures
AHA/ASA Ischemic Stroke Performance Measures 1. Venous thromboembolism prophylaxis Percentage of patients with ischemic stroke who receive venous thromboembolism prophylaxis Numerator Hospital day 0 or
More informationImaging of Acute Stroke. Noam Eshkar, M.D New Jersey Neuroscience Institute JFK Medical Center Edison Radiology Group
Imaging of Acute Stroke Noam Eshkar, M.D New Jersey Neuroscience Institute JFK Medical Center Edison Radiology Group Modalities Non Contrast CT (NCCT) Contrast CT Angiography MRI MR Angiography Perfusion
More informationDo We Need a New Definition of Stroke & TIA as Proposed by the AHA? Stroke & TIA need to Remain Clinical Diagnoses: to Change Would be Bonkers!
Do We Need a New Definition of Stroke & TIA as Proposed by the AHA? No Stroke & TIA need to Remain Clinical Diagnoses: to Change Would be Bonkers! A/Prof Anne L. Abbott Neurologist School of Public Health
More informationThe International Agenda for Stroke
1st Global Conference on Healthy Lifestyles and Noncommunicable Diseases Control Moscow, 28-29 April, 2011 The International Agenda for Stroke Marc Fisher MD, University of Massachusetts Editor-in-Chief,
More informationStroke Care First week
Stroke Care First week Florence Nightingale (1820 1910) Stroke Unit Dedicated personnel trained in stroke management Stepwise guidelines supported by explicit checklists Continuous monitoring available
More informationSlumping, Slurring and Slipping Away: Stroke Assessment. Laurie A. Romig, MD, FACEP Medical Director Pinellas County (FL) EMS
Slumping, Slurring and Slipping Away: Stroke Assessment Laurie A. Romig, MD, FACEP Medical Director Pinellas County (FL) EMS Caution! This discussion relates only to nontraumatic neurological problems!
More informationPRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators
Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PRECOMBAT Trial Seung-Whan Lee, MD, PhD On behalf
More informationStroke/VTE Quality Measure Build for Meaningful Use Stage 1
Stroke/VTE Quality Measure Build for Meaningful Use Stage 1 Presented by Susan Haviland, BSN RN Senior Consult, Santa Rosa Consulting Meaningful Use Quality Measures Centers for Medicare and Medicaid Services
More informationAccreditation and Certification Guidelines
Accreditation and Certification Guidelines MARTIN GIZZI, MD, PHD, FAHA CHAIR, NJ NEUROSCIENCE INSTITUTE AT JFK CHAIR, NORTH EAST CEREBROVASCULAR CONSORTIUM (NECC) CHAIR, STROKE ADVISORY PANEL, NJDOH MEMBER,
More informationREMINDER: Please ensure all stroke and TIA patients admitted to hospital are designated as "Stroke Service" in Cerner.
ACUTE STROKE CLINICAL PATHWAY QEH/HH PCH KCMH Souris Western Stewart Memorial O'Leary PATIENT ID INCLUSION CRITERIA* All patients admitted to hosptial with a suspected diagnosis of acute ischemic stroke
More informationACUTE STROKE REGISTRY (NJASR) VERSION 2.0) (Continued)
New Jersey Department of Health ACUTE STROKE REGISTRY (NJASR) VERSION 2.0 A. DEMOGRAPHIC DATA *Hospital Type (1): 1=Primary 2=Comprehensive 3=Other *Hospital Code (2): *Hospital Transferred From Code (3):
More informationSTROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:
STROKE PREVENTION IN ATRIAL FIBRILLATION TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention
More informationSystolic Blood Pressure Intervention Trial (SPRINT) Principal Results
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and
More informationWhat You Should Know About Cerebral Aneurysms
What You Should Know About Cerebral Aneurysms From the Cerebrovascular Imaging and Interventions Committee of the American Heart Association Cardiovascular Radiology Council Randall T. Higashida, M.D.,
More informationStroke Transfers. Downstate Receiving Hospital Perspective
Stroke Transfers Downstate Receiving Hospital Perspective Jeffrey M. Katz, MD Director, North Shore University Hospital Stroke Center Assistant Professor of Neurology, Hofstra North Shore-LIJ School of
More informationAcute Stroke: Evaluation and Treatment
Evidence Report/Technology Assessment Number 127 Acute Stroke: Evaluation and Treatment Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither
More informationThe Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke
More informationNew Anticoagulants and GI bleeding
New Anticoagulants and GI bleeding DR DANNY MYERS MD FRCP(C) CLINICAL ASSISTANT PROFESSOR OF MEDICINE, UBC Conflicts of Interest None I am unbiased in the use of NOAC s vs Warfarin based on risk benefit
More informationEvidence-Based Secondary Stroke Prevention and Adherence to Guidelines
Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines Mitchell S.V. Elkind, MD, MS Associate Professor of Neurology Columbia University New York, NY Presenter Disclosure Information Mitchell
More informationMedical Management of Ischemic Stroke: An Update. Siddharth Sehgal, MD Medical Director, TMH Neuroscience Center
Medical Management of Ischemic Stroke: An Update Siddharth Sehgal, MD Medical Director, TMH Neuroscience Center Objectives Diagnostic evaluation and management of acute ischemic stroke. Inpatient management
More informationA list of FDA-approved testosterone products can be found by searching for testosterone at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/.
FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke
More informationCerebral Hemorrhage Following Thrombolysis in Stroke
Von Kummer Cerebral Hemorrhage Following Thrombolysis in Stroke Rüdiger von Kummer SUMMARY Hemorrhagic transformation (HT) of ischemic brain tissue occurs in treated and non-treated stroke patients with
More informationTypes of Brain Injury
Types of Brain Injury The bones of your skull are hard and they protect your brain. Your brain is soft, like firm Jell-O. When your head moves, your brain moves inside your skull. When your head is hit
More informationCost Effectiveness of Helicopter Transport of Stroke Patients for Thrombolysis
966 Silbergleit et al. d HELICOPTER TRANSPORT IN STROKE Cost Effectiveness of Helicopter Transport of Stroke Patients for Thrombolysis Abstract Objectives: Treatment with intravenous (IV) or intra-arterial
More informationStroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012
Faculty Prevention Sharon Ewer, RN, BSN, CNRN Stroke Program Coordinator Baptist Health Montgomery, Alabama Satellite Conference and Live Webcast Monday, May 21, 2012 2:00 4:00 p.m. Central Time Produced
More informationThe New Complex Patient: The Shifting Locus of Care and Cost. Does Technology Keep Patients Out of Hospitals?
The New Complex Patient: The Shifting Locus of Care and Cost Does Technology Keep Patients Out of Hospitals? Lee H. Schwamm, MD Executive Vice Chairman, Department of Neurology, Director of Stroke Services
More informationDespite the increase in the global burden of stroke, advances
AHA/ASA Guideline Guidelines for the Early Management of Patients With Acute Ischemic Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The
More information